# Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial

Source: https://onco.cc/trials/nct05744219/  
OnCo record `nct05744219` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial in pancreatic cancer, run by Jon Unosson, now recruiting.

## Summary

Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial is a phase 3, randomised interventional study registered as NCT05744219 by Jon Unosson, with a registry enrolment figure of 338 participants, started 2024-09-04 and due to reach its primary completion in 2027-12-31. Interventions recorded: Ferric carboxymaltose; Placebo. Conditions listed: Surgery; Liver Metastases; Liver Cancer; Pancreas Cancer; Aortic Aneurysm. Primary outcome: Recovery after iv Iron. Pancreatic eligibility wording from the registry: "Scheduled for complex aortic surgery, liver resection or pancreatic resection". Sites: Sweden. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Also known as: IRIS
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT05744219
- Phase: 3
- Setting: Improved Recovery by Iron Following Surgery With Blood Loss, a Double-blind Multi-centre Randomized Controlled Phase III Drug Trial (the IRIS-trial)
- Sponsor: Jon Unosson
- Enrolled: 338

## Sources

- ClinicalTrials.gov NCT05744219: https://clinicaltrials.gov/study/NCT05744219

## Connected records

- cancers: [Metastatic pancreatic ductal adenocarcinoma](https://onco.cc/cancers/metastatic-pdac/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct05744219.json